Diagnostic and progression biomarkers in cerebrospinal fluid of Alzheimer's disease patients.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 38331825.
- Also identified by DOI 10.1186/s12916-024-03270-w and PMC identifier 10854014.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
In this commentary, we address a paper published by Johnson et al. by assessing the robustness of their method to discover diagnostic biomarkers in Alzheimer's disease (AD). In addition, we examine how these newly discovered and previously discovered biomarkers, can play a role in assisting patients with AD and those at risk for developing AD, with an emphasis on the translational hurdles that accompany such discoveries.
Medical subject headings
- Alzheimer Disease